Testing for Estrogen (ER) and Progesterone (PR) receptors expression for breast cancer patients are routinely done in many parts of the world, as determination of estrogen and progesterone receptors expression determines the patients who will benefit from adjuvant hormonal therapy. Here, PGR is linked to breast carcinoma.